glp 1 drugs menopause Semaglutide and Menopause: Does It Work? GLP-1 Agonists in Perimenopause: Unique

As oral GLP-1 options expand and employee awareness grows, more employers may soon need a strategy, whether theyre ready or not.

Interest was higher among women, with nearly one in 10 (8.9%) saying they would be likely or very likely to consider using them in the next year, and among people aged 45 to 55 (9.7%)

Jenkins DJ, Wolever TM, Collier GR, Ocana A, Rao AV, Buckley G, et al

Starting with lower doses (5 grams or less) and gradually increasing intake can help minimize these effects

The development of multiagonists, including GLP-1glucagon and GIPGLP-1glucagon receptor agonists, especially with the potential for glucagon receptor activation, marks a significant advancement in the field

J Exp Biol 214:242253